We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting fi... AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Show more
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.68 | -6.73267326733 | 10.1 | 10.4604 | 9.37 | 31907 | 9.77360042 | CS |
| 4 | -0.884 | -8.57919254658 | 10.304 | 11.96 | 7.96 | 314453 | 9.48844878 | CS |
| 12 | -5.898 | -38.5037211124 | 15.318 | 17.25 | 7.96 | 382356 | 11.49851102 | CS |
| 26 | -8.1359 | -46.3428249193 | 17.5559 | 24.15 | 7.96 | 284104 | 14.70155053 | CS |
| 52 | -6.8203 | -41.9961453914 | 16.2403 | 24.15 | 7.96 | 394051 | 16.16982563 | CS |
| 156 | -166.76 | -94.6531955954 | 176.18 | 236.67 | 7.96 | 698770 | 74.94431866 | CS |
| 260 | -3.6026 | -27.6642145194 | 13.0226 | 1126.08 | 7.96 | 557776 | 166.33266091 | CS |
| Symbol | Price | Vol. |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0.764 (321.87%) | 729.72M |
| NVDANVIDIA Corporation | US$ 120.07 (-3.67%) | 388.54M |
| RIMEAlgorhythm Holdings Inc | US$ 0.02565 (5.12%) | 338.75M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0.0355 (-11.25%) | 236.29M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0.1938 (30.77%) | 234.8M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
